Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

VITL

Explore full profile

VITL - Premium Supplements Online

London, United KingdomFounded 2015Health Tech & Medtech
Valuation $25–50M Last recorded · 2022
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for VITL and the history behind them.

About VITL

Founded in 2015 by Jonathan Relph and Oliver Bolton, VITL operates within the personalized health and wellness market, offering a data-driven approach to nutrition. The company's genesis stems from founder Jonathan Relph's background in finance, where his work with medical technology companies revealed a growing trend of individuals using data from fitness apps to inform their health decisions. This insight, combined with a dissatisfaction for the generic supplements available, inspired the creation of a more personalized and modern nutrition service.

VITL's business model is centered on a direct-to-consumer, subscription-based service, supplemented by a growing retail presence. The company generates revenue by selling personalized vitamin packs, at-home test kits, and a range of formulated supplements. Customers begin with a free five-minute online consultation that assesses their diet, lifestyle, and health goals. Based on this AI-powered analysis, VITL recommends a tailor-made vitamin regimen delivered monthly. For deeper personalization, clients can opt for at-home DNA and blood tests, which analyze various biomarkers like vitamin levels, cholesterol, and genetic predispositions related to nutrient absorption. The results are used to further refine supplement recommendations and provide personalized health advice.

The product suite includes daily vitamin packs, specific supplements for goals like sleep or beauty, and recently, a line of vitamin and protein bars. All supplements are formulated to be non-GMO and free from synthetic fillers, sugar, and gluten. Initially a direct-to-consumer brand, VITL has expanded its reach through partnerships with major UK retailers such as Sainsbury's, Boots, and Holland & Barrett. The company has successfully raised approximately $13.4 million over several funding rounds, with a significant Series A round in February 2022 to fuel product expansion and entry into new markets.

Source: Dealroom company data

At a glance

Founded
2015
Headquarters
London, United Kingdom
Sector
Health Tech & Medtech

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed7 investors entered at this stage

Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇬🇧 United Kingdom84.6%
🇵🇱 Poland7.7%
🇮🇪 Ireland7.7%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about VITL on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See VITL on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.